http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012146325-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
filingDate 2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2012146325-A
titleOfInvention THERAPEUTIC OR PREVENTIVE MEANS FOR THE TREATMENT OF FIBROMYALGIA
abstract 1. A therapeutic agent or prophylactic agent for treating fibromyalgia, said agent containing as an effective ingredient a cyclohexane derivative represented by the formula (I): wherein A is a substituent represented by the formula (IIa) or (IIb) :; R and R are each independently the other is a hydrogen atom, a chlorine atom, a C — C haloalkyl group, a CC alkyl group or a CC alkoxy group, R represents a hydrogen atom or a chlorine atom; R represents a fluorine atom, a hydroxymethyl group or a hydroxyl group; R and R each independently represent a hydrogen atom, a fluorine atom, a C-C haloalkyl group, a carboxyl group, a methoxycarbonyl group, an ethoxy-carbonyl group, a C-C-alkoxy group , a hydroxyl group or a C-C-alkylcarbonyloxy group, or optionally together form an oxo group; R and R each independently of each other represents a hydrogen atom or a fluorine atom; Y represents an oxygen atom or a sulfur atom; Z represents second nitrogen atom or a methine group; or a pharmaceutically acceptable salt or egoprolekarstvo.2. The therapeutic agent or prophylactic according to claim 1, wherein R and R are each independently a trifluoromethyl group, a methyl group or a methoxy group. The therapeutic agent or prophylactic according to claim 1 or 2, wherein R1 is a hydrogen atom. A therapeutic agent or prophylactic agent according to any one of claims 1 to 2, wherein R 1 is a hydroxymethyl group or a hydroxyl group. Therapeutic agent or prophylactic �
priorityDate 2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393647

Total number of triples: 38.